It makes one wonder who else from Actavis was in the room at DEA HQ on that day in September 2012. Did all Actavis senior management share the sentiment of VP Mr. Clarke- that the DEA seemed to consider them akin to a "street dealer" and particularly responsible for the opioid crisis in the United States? It also makes one wonder whose interests were being served a few years later when Elite Pharma's opioid ANDAs were dumped by the CEO for pennies on the dollar. Who really needed to get away from generic opioids- was it the company or was it the man? It seems to me ELTP has clean hands.
The article makes clear the Sacklers at Purdue were a soft touch compared to the anonymous execs at Actavis, Mallinckrodt, and Endo. America got kicked in the teeth while the international conglomerates made billions and billions of dollars selling smack in the mountains and all along the I-10. Elite Pharma had nothing to do with any of it, but ELTP shareholders continue to suffer the consequences.